SaranyaChumsriMD

PubMed

• 206 citations
  Aromatase, aromatase inhibitors, and breast cancer.
  Saranya Chumsri, Timothy Howes, Ting Bao, Gauri Sabnis, Angela Brodie
  The Journal of Steroid Biochemistry and Molecular Biology. 2011-05-01
• 60 citations
  Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade inv...
  Prasun Guha, Gargi Bandyopadhyaya, Swamy K. Polumuri, Saranya Chumsri, Padmaja Gade
  Breast Cancer Research and Treatment. 2014-03-26
• 117 citations
  Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
  Daniel L. Adams, Steingrimur Stefansson, Christian C. Haudenschild, Stuart S. Martin, Monica S. Charpentier
  Cytometry. Part A. 2015-02-01

Journal Articles

• Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings:...  
  Bhatnagar B, Gilmore S, Goloubeva O, Pelser C, Medeiros M, Chumsri S, Tkaczuk K, Edelman M, Bao T, Springerplus, 7/1/2014
•  
  Guha P, Bandyopadhyaya G, Polumuri SK, Chumsri S, Gade P, Kalvakolanu DV, Ahmed H, Breast Cancer Res Treat, 5/1/2014
• Circulating Giant Macrophages as a Potential Biomarker of Solid Tumors  
  Adams D, Martin S, Alpaugh K, Charpentier M, Tsai S, Bergan R, Ogden IM, Catalona W, Chumsri S, Tang CM, Cristofanilli, Proc Natl Acad Sci USA, 2/18/2014
• Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer  
  Kazi A, Gilani RA, Schech AJ, Chumsri S, Sabnis GJ, Shah P, Goloubeva O, Kronsberg S, Brodie AH, Breast Cancer Res, 1/1/2014
• Outcomes and Chemotherapy-related Toxicity in HIV-infected Patients With Breast Cancer  
  Singh SN, Zhu Y, Chumsri S, Kesmodel S, Gilliam BL, Riedel DJ, Clin Breast Cancer, 11/20/2013
• Radiation Resistance of Cancer Stem Cells as an Obstacle in Cancer Therapy  
  Chumsri S, Shah P, Mol Cell Pharmacol, 1/1/2013
• The effect of atazanavir on doxorubicin pharmacokinetics: A case report  
  Sheth NU, Gilmore S, Bauer K, Chumsri S, JHOP, 1/1/2013
• Increasing National Mastectomy Rates for the Treatment of Early Stage Breast Cancer  
  Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, Cheston SB, Regine WF, Feigenberg SJ, Ann Surg Oncol, 11/8/2012
• The importance of HER2 in the tumor initiating cell population in aromatase inhibitor resistant breast cancer  
  Gilani R, Kazi AA, Shah P, Schech AJ, Chumsri S, Sabnis GJ, et al, Breast Cancer Res Treat, 10/1/2012
• MiR-200a regulates SIRT1 and EMT-like transformation in mammary epithelial cells  
  Eades, G., Yao, Y., Yang, M., Zhang, Y., Chumsri, S., Zhou, Q., J Biol Chem, 7/1/2011
•  
  Gauri, S., Goloubeva, O., Chumsri, S., Nguyen, N., Sukumar, S., Brodie, A., Cancer Res, 3/1/2011
• Extending aromatase inhibitor sensitivity in hormone resistant breast cancer  
  Brodie, AMH., Chumsri, S., Sukumar, S., Sabnis, G, Horm Mol Biol Clin Invest, 1/1/2011
• A role of Oct4 in Tumor initiation of drug-resistant prostate cancer cells  
  Linn, D., Yang, X., Sun, F., Xie, Y., Chen, H., Jian, R., Chen, H., Chumsri, S., Burger, A., Qiu, Y., Genes Cancer, 9/1/2010
• Review Article: Leukemic stem cell pathways – therapeutic implications  
  Chumsri S, Matsui W, Burger AM, Clin Cancer Res, 11/1/2007
• Centro-lobular lung edema in transfusion-related acute lung injury (TRALI)  
  Chumsri S, Zimrin AB, Gibble JW, Hess JR, Transfusion, 1/1/2007
• Persistent Positron Emission Tomography Positivity Secondary to Benign Histiocytic Proliferation after Treatment of Hodgkin’s disease  
  Chumsri S, Tummala MK, Khan AM, Zhao XF, Rapoport AP, Leuk Lymphoma, 1/1/2007
• Review Article: Cancer stem cells and individualized therapy  
  Chumsri S, Phatak P, Edelman MJ, Khakpour N, Hamburger AW, Burger AM, Cancer Genomics & Proteomics, 1/1/2007
• Join now to see all

Books/Book Chapters

• Estrogen Action, SERMS and Women’s Health 
  Chapter: Advances with Aromatase Inhibitors. 
  Chumsri S, Bao T, Sabnis G, Brodie AEditors: V. Craig Jordan.World Scientific, Singapore2011
• AACR Educational Book 
  Chapter: Review Article: Leukemic stem cell pathways – therapeutic implications. 
  Chumsri S, Matsui W, Burger AM2008
• Cancer Research Journal 
  Chapter: Cancer stem cells. 
  Page 1935 - 2506Chumsri S, Burger AMEditors: Frank Columbus.Nova Science Publishers, Inc.2008

Abstracts/Posters

• Cancer in HIV-Positive Women: Clinicopathologic Features and Comparison with General Population.
  Kokh D, Rosenblatt R, Chumsri S, Kesmodel S, Ioffe O, The United States & Canadian Academy of Pathology’s 103rd Annual Meeting, 1/1/2014
• Effect of diet-induced obesity on MCF-7Ca xenografts grown in ovariectomized athymic nude mice.
  Sabnis G, Goloubeva O, Shah P, Chumsri S, Brodie A, AACR Annual Meeting, 1/1/2014
• HER2 regulated miRNA expression in letrozole resistant breast cancer.
  Kazi A, Sabnis G, Zhou Q, Chumsri S, Schech A, Shah P, Brodie A, AACR Annual Meeting, 1/1/2014
• Presentation and pathology of breast cancer in patients with HIV.
  Rosenblatt R, Singh SN, Goicochea L, Kesmodel S, Ioffe OB, Chumsri S, Riedel D, Breast Cancer Symposium, 1/1/2013
• Preclinical assessment of an HDAC inhibitor combined with a retinoid in AI resistant breast cancer.
  Shah P, Sabnis GJ, Goloubeva O, Kazi A, Schech A, Gilani R, Gau Y, Chumsri S, Brodie A, AACR Annual Meeting, 1/1/2013
• HDAC inhibitor entinostat reverses letrozole resistance in MCF-7Ca xenografts through modulation of Her-2.
  Sabnis GJ, Kazi A, Goloubeva O, Chumsri S, Brodie A, AACR Annual Meeting, 1/1/2013
• Inhibiiton of non-hypoxic HIF-1 expression in letrozole-resistant breast cancer cells reduces their cancer stem cell characteristics.
  Kazi AA, Shah P, Schech A, Sabnis G, Chumsri S, Brodie A, AACR Annual Meeting, 1/1/2013
• Identifying and subtyping circulating tumor cells from breast, prostate, and pancreatic cancer patients based on distinct morphology.
  Adams D, Alpaugh RK, Cristofanilli M, Martin S, Chumsri S, Charpentier M, Bergan RC, Ogden IM, Tsai S, Zhu P, Makarova OV, Li S, Amstutz PT, Tang CM, AACR Annual Meeting, 1/1/2013
• A Pilot Prospective Study of Adherence to Aromatase Inhibitor Adjuvant Therapy in Patients with Stage 1-3 Breast Carcinoma.
  Heiss B, Thompson J, Nightingale G, Tait N, Kesmodel S, Bellavance E, Chumsri S, Bao T, Goloubeva O, Feigenberg S, Tkaczuk K, San Antonio Breast Cancer Symposium, 12/1/2012
• Brown fat (BAT) seen on FDG PET/CT is increased in Breast Cancer patients (BC) compared to their age- and weight-matched controls with other cancers.
  Tkaczuk KHR, Cao Q, Jones L, Smith M, Chumsri S, Jenkins J, Dilsizian V, Chen W, European Society for Medical Oncology, 10/1/2012
• The effect on detection rate of second cancers after the addition of MRI to conventional screening mammagraphy in patients with a history of breast cancer.
  Weinstock C, Campassi C, Goloubeva O, Chumsri S, Bao T, Kesmodel S, Feigenberg S, Wooten K, Ioffe O, Tkaczuk K, American Society of Clinical Oncology, 6/1/2012
• Association between Vitamin D deficiency and breast cancer histology: a retrospective database review.
  Bhargava R, Zhu Y, Weinstock C, Hanna N, Tkaczuk K, Bao T, Chumsri S, American Society of Clinical Oncology, 6/1/2012
• Changes in Patient Reported Outcomes in Women with Breast Cancer in A Multi-Center Double Blind Randomized Controlled Trial Assessing the Effect of Acupuncture in Redu...
  Bao T, Betts K, Tarpinian K, Cai L, Gould J, Jeter S, Medeiros M, Tait N, Chumsri S, Armstrong D, Bardia A, Tan M, Stebbing J, Kelleher W, Folkerd E, Dowsett M, Singh ..., American Society of Clinical Oncology, 6/1/2012
• Involvement of HER2, HIF-1, and BCRP in cancer stem cell characteristics of letrozole-resistant breast cancer cells.
  Gilani R, Kazi A, Scheh A, Chumsri S, Shah P, Brodie A, AACR Meeting Abstracts, 4/1/2012
• A Multi-Center Randomized Controlled Double Blind Trial Assessing the Effect of Acupuncture in Reducing Musculoskeletal Symptoms in Breast Cancer Patients Taking Aroma...
  Bao T, Tarpinian K, Medeiros M, Gould J, Jeter S, Cai L, Tait NS, Shetty J, Lewis JC, Gittens L, Betts K, Hoffman A, Feigenberg SJ, Chumsri S, Giles J, Armstrong D, Ba..., San Antonio Breast Cancer Symposium, 12/1/2011
• The safety and tolerability of vorinostat in combination with lapatinib in advanced solid tumors.
  Chumsri S, Tait NS, Medeiros M, Bauer KS, Betts KT, Lewis JC, Bao T, Feigenberg S, Kesmodel S, Stearns V, Edelman MJ, Sausville E, Tkaczuk KH, San Antonio Breast Cancer Symposium, 12/1/2011
• The potential role of nonhypoxic HIF-1 in HER2 mediated aromatase inhibitor resistant breast cancer.
  Kazi A, Gilani R, Chumsri S, Brodie A, AACR Meeting Abstracts, 4/1/2011
• Breast cancer in patients with HIV: A single-institution experience with a non-AIDS defining cancer.
  Singh SN, Baer MR, Tkaczuk KH, Chumsri S, Bao T, Riedel D, J Clin Oncol, 1/1/2011
• Early evidence of increasing national mastectomy rates for the treatment of breast cancer.
  Mahmood UA, Hanlon L, Koshy M, Buras R, Chumsri S, Tkaczuk KH, Cheston S, Regine W, Feigenberg SJ, J Clin Oncol; Breast Cancer Symposium, 1/1/2011
• Comparing survival with breast-conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
  Mahmood U, Morris CG, Neuner GA, Koshy M, Kesmodel S, Buras R, Chumsri S, Bao T, Tkaczuk KH, Feigenberg SJ, J Clin Oncol; Breast Cancer Symposium, 1/1/2011
• Regulation of breast cancer metabolism and glycolysis by RUNX2.
  Choe M, Chumsri S, Girnun G, Passaniti, Cancer Biology Research Retreat, 5/1/2010
• A functional role of OCT4 for prostate tumor initiation.
  Linn D, Yang X, Sun F, Xie Y, Chumsri S, Burger A, Qiu Y, AACR Meeting Abstracts, 4/1/2010
• Aromatase inhibitors and xenograft studies.
  Chumsri S, Sabnis G, Howes, T, Brodie A, Aromatase Proceeding, 1/1/2010
• Drug Response Indicator Test (DRIT) as a predictive test for treatment outcomes in advanced breast cancer patients (ABC).
  Tkaczuk KH, Tait NS, Ioffe O, Tan M, Mohiuddin M, Chumsri S, VanEcho DA, Sutula MJ, Lesko S, Deamond S, Ts'o P, ASCO Annual Meeting, 6/1/2009
• All-trans retinoic acid in combination with trastuzumab can induce differentiation and diminish breast cancer stem cells in endocrine resistant breast cancer.
  Gilani R, Chumsri S, Sabnis G, Brodie A, AACR Meeting Abstracts, 4/1/2009
• Join now to see all

Lectures

• Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial). 
  2019 ASCO Annual Meeting - 6/1/2019
• Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoAL... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Balancing Efficacy with Tolerability in the Management of Metastatic Breast Cancer 
  Florida Hospital Fish Memorial Cancer Institute, Orange City, FL - 5/9/2014
• Physical Examination for Medical Students 
  University of Maryland School of Medicine, Baltimore, MD - 1/1/2014
• Therapies for Advanced HER2-Positive Breast Cancer: Leveraging Molecular Pathways in Resistant Disease 
  Alle-Kiski Cancer Center, Natrona Heights, PA - 8/5/2013
• Reprogramming breast cancer using HDAC inhibitor. 
  Johns Hopkins, Baltimore, MD - 11/6/2012
• Update on Breast Cancer Clinical Trials at the University of Maryland Cancer Center 
  University of Maryland, Baltimore, MD - 10/26/2012
• The First Bench to Bedside Grand Rounds: Aromatase Inhibitors 
  University of Maryland, Baltimore, MD - 10/24/2012
• Adjuvant Chemotherapy for stage I-III Breast Cancer 
  University of Maryland School of Medicine, Baltimore, MD - 10/18/2012
• Triple Negative Breast Cancer: An Update on Novel Systemic Therapies 
  University of Maryland, Baltimore, MD - 11/30/2011
• Breast Cancer Updates in 2011 
  University of Maryland, Baltimore, MD - 9/19/2011
• Medical Oncology Aspects of Early Stage Breast Cancer 
  University of Maryland School of Medicine, Baltimore, MD - 8/31/2011
• Updates in Adjuvant Therapy for Breast Cancer and Steps for Personalized Therapy 
  7/28/2011
• Updates from San Antonio Breast Cancer Symposium 
  University of Maryland, Baltimore, MD - 2/11/2011
• Chemotherapy for Stage I-III Breast Cancer 
  University of Maryland School of Medicine, Baltimore, MD - 11/11/2010
• Emerging Trends in Breast Cancer 2010 
  University of Maryland, Baltimore, MD - 10/4/2010
• Medical Oncology Aspects of Breast Cancer 
  University of Maryland School of Medicine, Baltimore, MD - 8/4/2010
• Adjuvant Therapy in Breast Cancer 
  University of Maryland School of Medicine, Baltimore, MD - 5/20/2010
• Histone Deacetylase Targeting as a Method for Re-establishing Hormone Responsiveness in Breast Cancer 
  University of Chicago, IL - 4/23/2010
• Systemic Adjuvant Therapy for Early Stage Breast Caner 
  University of Maryland, Baltimore, MD - 11/6/2009
• Novel Predictive and Prognostic Biomarkers in Breast Cancer 
  Upper Chesapeake Hospital, MD - 10/10/2009
• Current Investigator Initiation Trials for Breast Cancer 
  University of Maryland, Baltimore, MD - 9/25/2009
• Breast Cancer Board Review 
  University of Maryland School of Medicine, Baltimore, MD - 6/26/2009
• Hormone Therapy in Breast Cancer 
  University of Maryland School of Medicine, Baltimore, MD - 5/21/2009
• Gonadal Hormones and Inhibitors 
  University of Maryland School of Medicine, Baltimore, MD - 4/29/2009
• Join now to see all